Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, Carolyn, Ramirez, Sydney I., Dan, Jennifer M., Grifoni, Alba, Hastie, Kathryn M., Weiskopf, Daniela, Belanger, Simon, Abbott, Robert K. +16 more·2020·Cell

DOI 10.1016/j.cell.2020.09.038

Cited by (1,001)

Items 701–800 of 1,001

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
Katja G. Schmidt, Krystelle Nganou‐Makamdop, Matthias Tenbusch, Boutaina El Kenz, Clara Maier, Dennis Lapuente, Klaus Überla, Bernd M. Spriewald, Silke Bergmann, Ellen G. Harrer et al. · 2021 · Frontiers in Immunology
Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
Youfang Cao, Wei Gao, Luzelena Caro, Julie A. Stone · 2021 · Clinical and Translational Science
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen · 2021 · Frontiers in Immunology
Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity
Johannes Schetelig, Falk Heidenreich, Henning Baldauf, Sarah Trost, Bose Falk, Christian Hoßbach, Ruben G. L. Real, Axel Roers, Dirk Lindemann, Alexander H. Dalpke et al. · 2021 · Frontiers in Immunology
Waning immunity six months after BioNTech/Pfizer COVID-19 vaccination among nursing home residents in Zagreb, Croatia
Branko Kolarić, Andreja Ambriović‐Ristov, Irena Tabain, Tatjana Vilibić‐Čavlek · 2021 · Croatian Medical Journal
Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
Donald J. Alcendor, Patricia Matthews-Juarez, Duane T. Smoot, James E. K. Hildreth, Kimberly D. Lamar, Mohammad Tabatabai, Derek M. Wilus, Paul D. Juárez · 2022 · Vaccines
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Rebecca Svanberg Teglgaard, Cameron Ross MacPherson, Adrian G. Zucco, Rudi Agius, Tereza Faitová, Michael Asger Andersen, Caspar da Cunha‐Bang, Lars Klingen Gjærde, Maria Elizabeth Engel Møller, Patrick Terrence Brooks et al. · 2022 · Communications Medicine
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
Paola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Vincenzo Raimondi, Denise Toscani, Jessica Burroughs-Garcìa, Federica Costa, Benedetta Dalla Palma et al. · 2022 · OncoImmunology
Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa
Kesego Tapela, Fatima O. Oyawoye, Charles Ochieng’ Olwal, Precious Chinonyerem Opurum, Jones Amo Amponsah, Kekeli Aku Lumor Segbedzi, Becky Ewurama Tetteh, Frederick Kumi-Ansah, Joe Kimanthi Mutungi, Evangeline Obodai et al. · 2022 · BMC Medicine
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
Shin‐ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, Kanako Shimizu · 2022 · Inflammation and Regeneration
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
Maarten E. Emmelot, Martijn W. Vos, Mardi C. Boer, Nynke Y. Rots, Cécile A. C. M. van Els, Patricia Kaaijk · 2022 · Viruses
SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
David B. Reeg, Maike Hofmann, Christoph Neumann‐Haefelin, Robert Thimme, Hendrik Luxenburger · 2023 · Pathogens
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A. Johnson, Eloise Phillips, Sandra Adele, Stéphanie Longet, Tom Malone, Chris JB Mason, Lizzie Stafford, Anni Jämsén, Siobhan Gardiner, Alexandra S. Deeks et al. · 2023 · Clinical & Experimental Immunology
Immune Dysregulation in Acute SARS-CoV-2 Infection
Lauren Grimm, Chinyere Onyeukwu, Grace Kenny, Danielle M. Parent, Jia Fu, Shaurya Dhingra, Emily Yang, James N. Moy, Paul J. Utz, Russell P. Tracy et al. · 2023 · Pathogens and Immunity
COVID-19: from immune response to clinical intervention
Zheng-yang Guo, Yanqing Tang, Zi-bo Zhang, Juan Liu, Yuxin Zhuang, Ting Li · 2024 · Precision Clinical Medicine
Adaptive immunity and vaccination – iron in the spotlight
Alexandra E. Preston, Hal Drakesmith, Joe N. Frost · 2021 · Immunotherapy Advances
SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women
Li‐En Hsieh, Alba Grifoni, Hiral Dave, Jasmine Wang, Diana Johnson, Jennifer A. Zellner, John Sidney, Christina Chambers, Alessandra Franco · 2021 · Journal of Reproductive Immunology
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andrés F. Vallejo, Stephen Poole, Nathan James Brendish, Xiaofeng Dong, Catherine S. Hartley, John W. Holloway, Jane S. Lucas et al. · 2022 · Frontiers in Immunology
A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
Sojeong Kim, Sang Won Lee, June‐Young Koh, Donghoon Choi, Minkyu Heo, Jae‐Yong Chung, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee et al. · 2022 · Blood Advances
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice
Alexandra J. Spencer, Paul F. McKay, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, Cameron Bissett, Kai Hu, Karnyart Samnuan, Anna K. Blakney, Daniel Wright, Hannah Sharpe et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
In-depth characterization of T cell responses with a combined Activation-Induced Marker (AIM) and Intracellular Cytokine Staining (ICS) assay
Ye Ji Lee, Alison Tarke, Alba Grifoni · 2024 · Oxford Open Immunology
HIV infection and immunosenescence: challenges and intervention strategies
Junyan Jin, Qianqian Xu, Xin Zhang, Aiwei Zhu, Wei Xia, Christiane Moog, Alex Siu Wing Chan, Tong Zhang, Bin Su · 2025 · BMC Medicine
Hubungan Tren Bersepeda dimasa Pandemi Covid-19 dengan Imunitas Tubuh Lansia
Ema Novita Deniati, Annisaa Annisaa · 2021 · Sport Science and Health
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients
Victor H. Ferreira, Tina M. Marinelli, Matthew Ierullo, Terrance Ku, Victoria G. Hall, Beata Majchrzak-Kita, Vathany Kulasingam, Atul Humar, Deepali Kumar · 2021 · The Journal of Infectious Diseases
Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques
Thalia Rodriguez, Hana M. Dobrovolny · 2021 · Royal Society Open Science
Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
Т. Л. Каронова, Igor Vladimirovich Kudryavtsev, Ksenia A. Golovatyuk, Arthur D. Aquino, Olga Kalinina, Alena T. Chernikova, Ekaterina Konstantinovna Zaikova, Д. А. Лебедев, Ekaterina S. Bykova, А. С. Головкин et al. · 2022 · Pharmaceuticals
Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review
Paraskevi C. Fragkou, Charalampos D. Moschopoulos, Rieke Reiter, Thilo Berger, Chrysanthi L. Skevaki · 2022 · Clinical Microbiology and Infection
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
Andrea Kanizsai, Tihamér Molnár, Réka Várnai, László Závori, Margit Tökés‐Füzesi, Zoltan Szalai, Janos Berecz, Péter Csécsei · 2022 · Vaccines
Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
Alessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, Rita Casetti, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera et al. · 2022 · Frontiers in Immunology
Evaluation of the Immunomodulatory Effects of Interleukin-10 on Peripheral Blood Immune Cells of COVID-19 Patients: Implication for COVID-19 Therapy
Saeid Najafi Fard, Elisa Petruccioli, Chiara Farroni, Linda Petrone, Valentina Vanini, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera, Assunta Navarra, Tonino Alonzi et al. · 2022 · Frontiers in Immunology
Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine
Nozomi Kuse, Yu Zhang, Takayuki Chikata, Hung The Nguyen, Shinichi Oka, Hiroyuki Gatanaga, Masafumi Takiguchi · 2022 · Nature Communications
IL-2 and IL-1β Patient Immune Responses Are Critical Factors in SARS-CoV-2 Infection Outcomes
Shereen Fawzy, M. Ahmed Mesaik, Badr Abdulmohsin Alsayed, Rashid Mir, Dnyanesh Balkrishna Amle · 2022 · Journal of Personalized Medicine
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
Ksenia V. Zornikova, Alexandra A. Khmelevskaya, Savely A. Sheetikov, Dmitry Olegovych Kiryukhin, Olga V. Shcherbakova, Aleksei Titov, Ivan V. Zvyagin, Grigory Aleksandrovich Efimov · 2022 · Communications Biology
A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
Xiaoxiao Jin, Xiaotao Kelvin Liu, Chuanlai Shen · 2022 · Virus Research
Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study
Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Carlos King Ho Wong, Xue Li, Eric Yuk Fai Wan, Joshua Sung Chih Wong, Esther W. Chan, Ian Chi Kei Wong et al. · 2023 · Emerging Microbes & Infections
Human lung organoid modelling of tissue-resident antiviral T cell responses
Joseph K. Rathkey, S. S. Choi, Vincent van Unen, Huimin Zhang, Min Liu, Jie Ding, Samira Alwahabi, António J. M. Santos, Vamsee V. A. Mallajosyula, Joshua Elbridge Chan et al. · 2026 · Nature
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity
Martin Potts, Alice Fletcher-Etherington, Katie Nightingale, Federica Mescia, Laura Bergamaschi, Fernando J. Calero‐Nieto, Robin Antrobus, James C. Williamson, Harriet T. Parsons, Edward L. Huttlin et al. · 2023 · Cell Reports
Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
Ziying Chen, Qingyuan Zhan, Linna Huang, Chen Wang · 2023 · Frontiers in Public Health
Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world study
Shuxia Wang, Jin Sun, Xin Zhang, Man Li, Bangguo Qin, Miao Liu, Nan Zhang, Shengshu Wang, Tingyu Zhou, Wei Zhang et al. · 2024 · EClinicalMedicine
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia
Nikolay S. Markov, Ziyou Ren, Karolina J. Senkow, Rogan A. Grant, Catherine A. Gao, Elizabeth S. Malsin, Lango Sichizya, Hermon G. Kihshen, Kathryn A. Helmin, Milica Jovisic et al. · 2024 · Nature Immunology
The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response
Seniha Başaran, Serap Şimşek Yavuz, Sevim Meşe, Atahan Çağatay, Alpay Medetalibeyoğlu, Oral Öncül, Halit Özsüt, Ali Ağaçfidan, Ahmet Gül, Haluk Eraksoy · 2021 · International Journal of Infectious Diseases
Complexity of immune responses in COVID-19
Michael William Mather, Laura Jardine, Benjamin James Talks, Louis C. S. Gardner, Muzlifah A. Haniffa · 2021 · Seminars in Immunology
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Susan R. Conway, Michael Daniel Keller, Catherine M. Bollard · 2022 · Blood
Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
Apoorva Munigela, Divya Tej Sowpati, Mitnala Sasikala, Sofia Banu, Archana Bharadwaj Siva, Jagadeesh Kumar, Chandrasekhar Nutalapati, Ravikanth Vishnubhotla, Anand V. Kulkarni, Payel Mukherjee et al. · 2022 · IJID Regions
Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
Ang Gao, Zhilin Chen, A. Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, Florencia Pereyra Segal, Mary Carrington, Mark M. Davis, H. Streeck et al. · 2021 · iScience
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps
Jiwoon Park, Jonathan Foox, TYLER D. HETHER, David Danko, Sarah E. Warren, Youngmi Kim, Jason Reeves, Daniel Butler, Christopher Mozsary, Joel A. Rosiene et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
de Mattos Barbosa, Mayara Garcia, Liu, Hui, Huynh, Daniel, Shelley, Greg, Keller, Evan T., Emmer, Brian T., Sherman, Emily, Ginsburg, David, Kennedy, Andrew A., Tai, Andrew W. et al. · 2021 · JCI Insight
Intranasal replicon SARS-CoV-2 vaccine produces protective respiratory and systemic immunity and prevents viral transmission
Madeleine F. Jennewein, Michael D. Schultz, Samuel Beaver, Peter Battisti, Julie Bakken, Derek J. Hanson, Jobaida Akther, Fen Zhou, Raodoh Mohamath, Jasneet Singh et al. · 2025 · Molecular Therapy
T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge
Jennifer A. Juno, Danika Lea Hill · 2021 · Current Opinion in Immunology
The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, Richard Henderson Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology
Detection and Quantification of Antibody to SARS-CoV-2 Receptor Binding Domain Provides Enhanced Sensitivity, Specificity and Utility
Carolina Rosadas, Maryam Khan, Eleanor L. Parker, Federica Marchesin, Ksenia Katsanovskaja, Macià Sureda-Vives, Natalia Fernández, Paul Anthony Randell, Ruth Harvey, Alice Lilley et al. · 2020 · Journal of Virological Methods
The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study
Daisuke Jubishi, Koh Okamoto, Kensuke Hamada, Takashi Ishii, Hideki Hashimoto, Takayuki Shinohara, Marie Yamashita, Yuji Wakimoto, Amato Otani, Naoko Hisasue et al. · 2022 · Human Vaccines & Immunotherapeutics
Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19
Richard Dannebaum, Phillip Suwalski, Hosseinali Asgharian, Zhipei Gracie Du, Hai Lin, January Mikolaj Weiner, Manuel Holtgrewe, Charlotte Thibeault, Melina Müller, Xiaomin Wang et al. · 2022 · EClinicalMedicine
Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
Hongguan Xing, Liyan Zhu, Pingping Wang, Guoping Zhao, Zhihua Zhou, Yi An Yang, Hong Zou, Xing Yan · 2022 · Frontiers in Immunology
SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype
Kazutaka Terahara, Takashi Sato, Yu Adachi, Keisuke Tonouchi, Taishi Onodera, Saya Moriyama, Lin Sun, Tomohiro Takano, Ayae Nishiyama, Ai Kawana‐Tachikawa et al. · 2022 · iScience
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
Eva Anna Marianne Baerends, Astrid Korning Hvidt, Joanne Reekie, Ole Schmeltz Søgaard, Nina Breinholt Stærke, Dorthe Raben, Henrik Ib Nielsen, Kristine Toft Petersen, Maria Ruwald Juhl, Işık Somuncu Johansen et al. · 2023 · iScience
Immunosenescence and Inflammaging in COVID-19
Faezeh Asghari, Amir Asghary, Naime Majidi Zolbanin, Fatemeh Faraji, Reza Jafari · 2023 · Viral Immunology
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
Matteo Augello, Valeria Bono, Roberta Rovito, Camilla Tincati, Silvia Bianchi, Lucia Taramasso, Antonio Di Biagio, Annapaola Callegaro, Franco Maggiolo, Elisa Borghi et al. · 2023 · iScience
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals
Ottavia M. Delmonte, Cihan Oguz, Kerry Dobbs, Katherine Myint‐Hpu, Boaz Palterer, Michael S. Abers, Deborah Draper, Meng Truong, Ian M. Kaplan, Rachel Gittelman et al. · 2023 · Journal of Allergy and Clinical Immunology
Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, Sai Nikhila Ghanta, Anusha Bommasani, Kuttiappan Anitha, R. Padmavathi, Krishna Chaitanya Amerneni, Radhika Chikatipalli, Mohan Krishna Ghanta et al. · 2024 · Reviews in Medical Virology
A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection
Xue Liu, Laurye Van Maele, Laura Matarazzo, Daphnée Soulard, Vinicius Alves Duarte da Silva, Vincent de Bakker, Julien Dénéréaz, Florian Patrick Bock, Michael Taschner, Jinzhao Ou et al. · 2024 · Cell Host & Microbe
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience
Alessandra D’Abramo, Serena Vita, Alessia Beccacece, Assunta Navarra, Raffaella Pisapia, Francesco Maria Fusco, Giulia Matusali, Enrico Girardi, Fabrizio Maggi, Delia Goletti et al. · 2024 · Frontiers in Medicine
Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination
Bennett Davenport, Thomas E. Morrison, Ross M. Kedl, Jared S. Klarquist · 2021 · The Journal of Immunology
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
C. Riou, Georgia Schäfer, E. du Bruyn, R. Goliath, C. Stek, H. Mou, D. Hung, K. Wilkinson, R. Wilkinson · 2021 · European Respiratory Journal
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study
Mary K. Foley, Samuel D. Searle, Ali Toloue Ostadgavahi, Ryan Booth, Alec Falkenham, Darryl Falzarano, Salvatore Rubino, Magen Ellen Francis, Mara McNeil, Christopher Richardson et al. · 2021 · EClinicalMedicine
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Belén Aparicio, Noëlia Casares, Josune Egea, Marta Ruiz, Diana Llópiz, Sheila Maestro, Cristina Olagüe, Gloria González‐Aseguinolaza, Cristian Smerdou, Ascensión López-Dı́az de Cerio et al. · 2021 · Emerging Microbes & Infections
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern
Zoë L. Lyski, Amanda E. Brunton, Matt Strnad, Peter E. Sullivan, Sarah A. R. Siegel, Fikadu Tafesse, Mark K. Slifka, William B. Messer · 2021 · The Journal of Infectious Diseases
Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction Delivery
Moonsup Jeong, Sagar B. Kudchodkar, Areum Gil, Bohyun Jeon, Gee Ho Park, Youngran Cho, Hyojin Lee, Mi Sun Cheong, Won‐Il Kim, Yun-Ho Hwang et al. · 2022 · Frontiers in Virology
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
Ai‐Min Hui, Jingxin Li, Li Zhu, Rong Tang, Huayue Ye, Mei Lin, Lei Ge, Xiyuan Wang, Fuzhong Peng, Zhenggang Wu et al. · 2022 · The Lancet Regional Health - Western Pacific
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH
Eeva Tortellini, Maria Antonella Zingaropoli, Giulia Mancarella, Raffaella Marocco, Anna Carraro, Meriem Jamhour, Christian Barbato, Mariasilvia Guardiani, Federica Dominelli, Patrizia Pasculli et al. · 2022 · International Journal of Molecular Sciences
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
T. Nomura, Hiroyuki Yamamoto, M. Nishizawa, T. Hau, S. Harada, Hiroshi Ishii, Sayuri Seki, Midori Nakamura-Hoshi, Midori Okazaki, Sachie Daigen et al. · 2021 · bioRxiv
Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron
Yu Gao, Curtis Cai, Alba Grifoni, Thomas R Müller, Julia Niessl, Anna Olofsson, Marion Humbert, Lotta Hansson, Anders Österborg, Peter Bergman et al. · 2022 · Nature Medicine
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis
Maurizio Benucci, Arianna Damiani, Francesca Li Gobbi, Barbara Lari, Valentina Grossi, Maria Giaele Infantino, Mariangela Manfredi · 2022 · Immunologic Research
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, Katherine Ellingson, Makiko Watanabe, Janko Nikolich‐Žugich · 2022 · The Journal of Immunology
SARS-CoV-2 epitopes inform future vaccination strategies
Areez Shafqat, Mohamed H. Omer, Omar Ahmad, Mahnoor Niaz, Humzah S. Abdulkader, Shameel Shafqat, Ali Hassan Mushtaq, Abdullah Shaik, Ahmed Nahid Elshaer, Junaid Kashir et al. · 2022 · Frontiers in Immunology
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Yoshiyuki Yahagi, Yoko Tabe, Naoto Tamura, Sachiko Miyake · 2022 · Scientific Reports
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
Lidewij W. Rümke, Wouter L. Smit, Ailko W. J. Bossink, Gijs J. M. Limonard, Danya Muilwijk, Lenneke E. M. Haas, Chantal B. E. M. Reusken, Sanne van der Wal, Bing J. Thio, Yvonne M. G. van Os et al. · 2023 · Frontiers in Immunology
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
Martina Milighetti, Yanchun Peng, Cedric C.S. Tan, Michal Mark, Gayathri Nageswaran, Suzanne Byrne, Tahel Ronel, Tom Peacock, Andreas Mayer, Aneesh Chandran et al. · 2023 · iScience
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
Alexandra Vujkovic, My Kieu Ha, Tessa de Block, Lida van Petersen, Isabel Brosius, Caroline Theunissen, Sabrina H. van Ierssel, Esther Bartholomeus, Wim J. Adriaensen, Guido L. Vanham et al. · 2023 · The Journal of Infectious Diseases
SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
Therese Bredholt Onyango, Fan Zhou, Geir Bredholt, Karl Albert Brokstad, Sarah Larteley Lartey, Kristin Greve-Isdahl Mohn, Türküler Özgümüş, Bård Reiakvam Kittang, Dagrun Waag Linchausen, Shahin Shafiani et al. · 2023 · Frontiers in Immunology
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S. Heitmann, Tanja Michel, Maddalena Marconato, Simon U. Jaeger, Christian Martin Tegeler, Monika Denk, Marion Richter, Melek Tutku Oezbek, Yacine Maringer et al. · 2023 · International Journal of Infectious Diseases
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Taraz Samandari · 2024 · Cellular and Molecular Immunology
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2
Sydney I. Ramirez, Paul G. Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz, Carlee Moser, Joseph J. Eron, David Alain Wohl, Judith S. Currier et al. · 2024 · JCI Insight
Late-onset Systemic Lupus Erythematosus
Prakashini Mruthyunjaya, Sakir Ahmed, Aliya Botabekova, Chokan Baimukhamedov, Olena Zimba · 2025 · Rheumatology International
The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19
Radostina Alexandrova, Pencho Beykov, Dobrin Iotkov Vassilev, Marko Jukič, Črtomir Podlipnik · 2020 · Biotechnology & Biotechnological Equipment
Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study
Bali Zhao, Maohua Zhong, Qingyu Yang, Ke Hong, Jianbo Xia, Xia Li, Ying Liu, Yao-Qing Chen, Jingyi Yang, Chaolin Huang et al. · 2021 · Virologica Sinica
Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level
Hannah Charlotte Copley, Loren A. Gragert, Andrew R. Leach, Vasilis Kosmoliaptsis · 2021 · Frontiers in Immunology
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
Mohd. Raeed Jamiruddin, Md. Ahsanul Haq, Mohib Ullah Khondoker, Tamanna Ali, Firoz Ahmed, Shahad Saif Khandker, Md. Irfan Jawad, Rubel Hossain, Sohel Ahmed, Sabita Rezwana Rahman et al. · 2021 · Expert Review of Vaccines
Immunology of SARS-CoV-2 infections and vaccines
Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
Gang Xu, Furong Qi, Haiyan Wang, Yu Liu, Xin Wang, Rongrong Zou, Jing Yuan, Xuejiao Liao, Yang Liu, Shuye Zhang et al. · 2022 · Frontiers in Immunology
IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
Jiong Wang, Dongmei Li, Andrew Cameron, Qian Zhou, Alexander Wiltse, Jennifer Lynn Nayak, Nicole Pecora, Martin Stuart Zand · 2022 · The Journal of Infectious Diseases
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
Christophe Capelle, Séverine Ciré, Olivia Domingues, Isabelle Ernens, Fanny Hedin, Aurélie Fischer, Chantal J. Snoeck, Wim Ammerlaan, Maria Konstantinou, Kamil Grzyb et al. · 2022 · Cell Reports Medicine
Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jennifer M. Dan, Ricardo da Silva Antunes, Alba Grifoni, Daniela Weiskopf, Shane Crotty, Alessandro Sette · 2022 · Clinical Infectious Diseases
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?
Rohan Ameratunga, Euphemia Yee Leung, See‐Tarn Woon, Lydia Chan, Richard Henderson Steele, Klaus Lehnert, Hilary J Longhurst · 2022 · The Journal of Allergy and Clinical Immunology In Practice
New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Allergy
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
Maika Takahashi, Tomohiko Ai, Konomi Sinozuka, Yuna Baba, Gene Igawa, Shuko Nojiri, Takamasa S. Yamamoto, Maiko Yuri, Satomi Takei, Kaori Saito et al. · 2022 · Scientific Reports
Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
Kouji Kobiyama, Masaki Imai, Nao Jounai, Misako Nakayama, Kou Hioki, Kiyoko Iwatsuki‐Horimoto, Seiya Yamayoshi, Jun Tsuchida, Takako Niwa, Takashi Suzuki et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
Guihai Liu, Elie Antoun, Anastasia Fries, Xuan Yao, Zixi Yin, Danning Dong, Wenbo Wang, Peter A. C. Wing, Wanwisa Dejnirattisa, Piyada Supasa et al. · 2025 · Nature Communications
Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk
Claudia Strafella, Valerio Caputo, Gisella Guerrera, Andrea Termine, Carlo Fabrizio, Raffaella Cascella, Mario Picozza, Carlo Caltagirone, Angelo Rossini, Maria Pia Balice et al. · 2021 · Frontiers in Immunology